CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on August 20, 2009
Clin J Am Soc Nephrol 4: 1551-1558, 2009
© 2009 American Society of Nephrology
doi: 10.2215/CJN.03980609

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.03980609v1
4/10/1551    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Barreto, F. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barreto, F. C.

Chronic Kidney Disease

Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

Fellype C. Barreto*,{dagger}, Daniela V. Barreto*,{dagger}, Sophie Liabeuf*,{dagger}, Natalie Meert{ddagger}, Griet Glorieux{ddagger}, Mohammed Temmar{dagger}, Gabriel Choukroun*,§, Raymond Vanholder{ddagger}, Ziad A. Massy*,{dagger},§, and on behalf of the European Uremic Toxin Work Group (EUTox)

* INSERM ERI-12 (EA 4292), Amiens, France; {dagger} Clinical Research Centre, Division of Clinical Pharmacology, Amiens University Hospital, and the Jules Verne University of Picardy, Amiens, France; {ddagger} Nephrology Section, Department of Internal Medicine, University Hospital, Gent, Belgium; and § Division of Nephrology, Amiens University Hospital, Amiens, France

Correspondence: Dr. Ziad A. Massy,INSERM ERI-12, Divisions of Clinical Pharmacology and Nephrology, Amiens University Hospital, Avenue Rene Laennec, F-80054 Amiens, France. Phone: + 33-322-455788; Fax: +33-322-455660; E-mail: massy{at}u-picardie.fr

Background and objectives: As a major component of uremic syndrome, cardiovascular disease is largely responsible for the high mortality observed in chronic kidney disease (CKD). Preclinical studies have evidenced an association between serum levels of indoxyl sulfate (IS, a protein-bound uremic toxin) and vascular alterations. The aim of this study is to investigate the association between serum IS, vascular calcification, vascular stiffness, and mortality in a cohort of CKD patients.

Design, setting, participants, & measurements: One-hundred and thirty-nine patients (mean ± SD age: 67 ± 12; 60% male) at different stages of CKD (8% at stage 2, 26.5% at stage 3, 26.5% at stage 4, 7% at stage 5, and 32% at stage 5D) were enrolled.

Results: Baseline IS levels presented an inverse relationship with renal function and a direct relationship with aortic calcification and pulse wave velocity. During the follow-up period (605 ± 217 d), 25 patients died, mostly because of cardiovascular events (n = 18). In crude survival analyses, the highest IS tertile was a powerful predictor of overall and cardiovascular mortality (P = 0.001 and 0.012, respectively). The predictive power of IS for death was maintained after adjustment for age, gender, diabetes, albumin, hemoglobin, phosphate, and aortic calcification.

Conclusions: The study presented here indicates that IS may have a significant role in the vascular disease and higher mortality observed in CKD patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Nephrology.